Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Late toxicities and outcomes of adjuvant radiotherapy combined with concurrent bevacizumab in patients with triple-negative non-metastatic breast cancer.
Pernin V, Belin L, Cottu P, Bontemps P, Lemanski C, De La Lande B, Baumann P, Missohou F, Levy C, Peignaux K, Reynaud-Bougnoux A, Denis F, Gobillion A, Bollet M, Vago NA, Dendale R, Campana F, Fourquet A, Kirova YM. Pernin V, et al. Among authors: reynaud bougnoux a. Br J Radiol. 2015 Apr;88(1048):20140800. doi: 10.1259/bjr.20140800. Epub 2015 Feb 3. Br J Radiol. 2015. PMID: 25645108 Free PMC article. Clinical Trial.
Evaluation at 3 years of concurrent bevacizumab and radiotherapy for breast cancer: Results of a prospective study.
Dautruche A, Belin L, Cottu P, Bontemps P, Lemanski C, de la Lande B, Baumann P, Missohou F, Lévy C, Peignaux K, Reynaud-Bougnoux A, Denis F, Gobillion A, Pernin V, Kirova Y. Dautruche A, et al. Among authors: reynaud bougnoux a. Cancer Radiother. 2018 May;22(3):222-228. doi: 10.1016/j.canrad.2017.10.004. Epub 2018 Apr 9. Cancer Radiother. 2018. PMID: 29650388
Toxicity of locoregional radiotherapy in combination with bevacizumab in patients with non-metastatic breast cancer (TOLERAB): Final long-term evaluation.
Clément-Zhao A, Tanguy ML, Cottu P, De La Lande B, Bontemps P, Lemanski C, Baumann P, Savignoni A, Levy C, Peignaux K, Reynaud-Bougnoux A, Gobillion A, Kirova Y. Clément-Zhao A, et al. Among authors: reynaud bougnoux a. PLoS One. 2019 Aug 30;14(8):e0221816. doi: 10.1371/journal.pone.0221816. eCollection 2019. PLoS One. 2019. PMID: 31469859 Free PMC article.
A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group.
Pautier P, Floquet A, Gladieff L, Bompas E, Ray-Coquard I, Piperno-Neumann S, Selle F, Guillemet C, Weber B, Largillier R, Bertucci F, Opinel P, Duffaud F, Reynaud-Bougnoux A, Delcambre C, Isambert N, Kerbrat P, Netter-Pinon G, Pinto N, Duvillard P, Haie-Meder C, Lhommé C, Rey A. Pautier P, et al. Among authors: reynaud bougnoux a. Ann Oncol. 2013 Apr;24(4):1099-104. doi: 10.1093/annonc/mds545. Epub 2012 Nov 8. Ann Oncol. 2013. PMID: 23139262 Free article. Clinical Trial.
[Pregnancy after breast cancer: A literature review].
Trefoux-Bourdet A, Reynaud-Bougnoux A, Body G, Ouldamer L. Trefoux-Bourdet A, et al. Among authors: reynaud bougnoux a. Presse Med. 2019 Apr;48(4):376-383. doi: 10.1016/j.lpm.2019.01.011. Epub 2019 Mar 27. Presse Med. 2019. PMID: 30926206 Review. French.
32 results